“…Studies about r-Hu-EPO administration before cardiac surgery have been reported in the literature. [20][21][22][23][24][25] Moreover, Watanabe and colleagues 26 reported the administration of the r-Hu EPO in the week after the operation in addition to preoperative use. Also, there are reports about administration of r-Hu EPO in multiple doses.…”
Recombinant human erythropoietin induces erythropoiesis rapidly, even when it is used with a low single dose just 4 days before the operation. No adverse reactions were seen with this kind of recombinant human erythropoietin treatment.
“…Studies about r-Hu-EPO administration before cardiac surgery have been reported in the literature. [20][21][22][23][24][25] Moreover, Watanabe and colleagues 26 reported the administration of the r-Hu EPO in the week after the operation in addition to preoperative use. Also, there are reports about administration of r-Hu EPO in multiple doses.…”
Recombinant human erythropoietin induces erythropoiesis rapidly, even when it is used with a low single dose just 4 days before the operation. No adverse reactions were seen with this kind of recombinant human erythropoietin treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.